Your First Month on Personalized Compounded Semaglutide

Your first month on personalized compounded semaglutide starts with a provider visit and a low weekly dose your provider sets. In research on FDA-approved semaglutide, nausea, diarrhea, vomiting and constipation were the most common side effects, mostly during dose increases. At Padgett in Ocala, the medication starts at $149 a month; the $100 visit is free if you start medication.

Padgett Medical Center offers personalized compounded semaglutide in Ocala, a weekly, medically supervised injection, at the clinic or by telehealth anywhere in Florida. The research figures below describe FDA-approved semaglutide, not Padgett's medication. New to these medicines? Read what GLP-1 medications are.

What happens at your first weight-loss visit?

Your provider decides whether personalized compounded semaglutide fits your health and, if it does, sets your starting dose. You'll meet with Sarah Weir, APRN, an advanced practice registered nurse, either at the clinic at 200 SW 8th St., Suite A, or on a telehealth visit while you are physically in Florida.

Bring a list of every medicine, vitamin and supplement you take. The Medication Guide for FDA-approved semaglutide asks patients to mention pancreas or kidney problems, diabetic eye disease (retinopathy) with type 2 diabetes, and any planned surgery or sedation. Its label rules out use with a personal or family history of medullary thyroid carcinoma, a type of thyroid cancer, or with multiple endocrine neoplasia syndrome type 2 (MEN 2).

Mention insulin or a sulfonylurea, a type of diabetes pill. The label for FDA-approved semaglutide says taking it with either one raises the chance of low blood sugar, and those medicines may need a lower dose. The label also advises against combining it with another GLP-1 medicine. For adults, NIDDK, part of the National Institutes of Health, says weight-management medicine may be prescribed at a body mass index (BMI) of 30 or more, or 27 or more with a weight-related problem; the BMI calculator shows yours.

No prescription is promised in advance. If your provider prescribes it, the medication is shipped to your door in Florida, with clear instructions for your exact medication. New to injections? Ask every question before your first dose.

Why does the first month start at a low dose?

Starting low gives your body time to adjust, and your provider chooses the dose. The prescribing information for FDA-approved semaglutide injection keeps its lowest dose for the first 4 weeks, then raises it every 4 weeks to lower the risk of stomach and bowel side effects.

A 2025 advisory from four medical and nutrition societies notes that in clinical trials people could stay at a dose for up to 8 weeks while side effects settled. At Padgett, your dose is personalized, and only your provider changes it. Don't raise, lower or skip a dose on your own.

Which side effects are common in the first few weeks?

Stomach and bowel effects lead the list. In the weight-loss trials behind the label for FDA-approved semaglutide injection, 73% of people on the drug reported one, versus 47% on placebo, and nausea was most frequent, at 44% versus 16%. Headache, tiredness and dizziness were also more common than on placebo. Those trials lasted up to 68 weeks, mostly at the usual maintenance dose, so the totals aren't a first-month snapshot.

A pooled analysis of the same three trials found 98% of the stomach side effects were mild or moderate. Most people who had one first noticed it during the trials' 16 weeks of dose increases, and nausea, diarrhea and vomiting were most common around week 20, then declined. Managing GLP-1 side effects covers what helps with each one.

How will your appetite change in the first month?

You may feel less hungry and fill up sooner; how much varies. In a 20-week study of FDA-approved semaglutide in 72 adults with obesity, people on the drug reported less hunger, more fullness and fewer, weaker food cravings. At a lunch where they could eat as much as they wanted, they ate more than a third fewer calories than the placebo group.

That study measured appetite at week 20, after the dose increases, not in week 1. The advisory describes less “food noise,” or preoccupation with food, and notes that some people develop food aversions, typically when treatment starts or the dose goes up. A smaller appetite can also mean going hours without eating, which the advisory says can leave you short on nutrients or craving sweets and refined carbohydrates later.

What should you eat while your appetite is low?

Plan small meals instead of waiting for hunger to tell you when to eat. The advisory says small, frequent meals may work when hunger and interest in food are low, and that smoothies made with fruit, vegetables and unsweetened milk or yogurt, cottage cheese and soups often appeal more than heavier foods such as red meat, cold cuts or hard cheese.

Eat the protein on your plate first, so a small appetite doesn't leave it behind, and set an alarm or reminder if you forget to eat; the advisory suggests both. Protein and muscle on a GLP-1 explains why protein matters.

Feeling queasy? Keep eating small amounts rather than skipping meals, which the advisory says can make nausea worse, and call the clinic if nausea keeps you from eating or drinking. Your provider may prescribe your weekly amount as two smaller injections, for example Monday and Thursday, when side effects call for it. Never change your schedule yourself. Splitting a tirzepatide dose twice a week explains why the FDA-approved label is once a week.

Why does drinking enough fluid matter so much?

Dehydration can harm your kidneys. The Medication Guide for FDA-approved semaglutide warns that nausea, vomiting and diarrhea can cause a loss of fluids, which may lead to kidney problems, and says drinking fluids helps lower that chance. The label describes reports of sudden kidney injury, some needing dialysis, mostly in people dehydrated by stomach side effects.

Sip fluids through the day, and drink more when you sweat in the Florida heat. In the label's trials, fluid loss was behind some cases of low blood pressure and fainting, and low blood pressure was more common in people on blood pressure medicine, so dizziness deserves a call. On a fluid limit for a heart or kidney condition? Ask your provider how much to drink.

When should you call your provider during the first month?

Call right away about stomach pain that is severe and won't go away, with or without nausea or vomiting, sometimes felt through to your back: the Medication Guide for FDA-approved semaglutide lists it as a sign of pancreatitis, an inflamed pancreas. Call right away, too, if nausea, vomiting or diarrhea won't stop. Pain in your upper stomach, fever, yellowing skin or eyes, or clay-colored stools can point to a gallbladder problem, so call about those as well.

The same guide asks you to report a racing or pounding heartbeat that lasts several minutes, and a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath. If you have type 2 diabetes, also report changes in your vision and signs of low blood sugar, such as shakiness, sweating or confusion.

Get medical help right away, such as by calling 911, for signs of a serious allergic reaction, including swelling of your face, lips, tongue or throat, trouble breathing or swallowing, or fainting. Otherwise, call the clinic at (352) 369-0104, Monday to Friday, 9:00 AM to 5:00 PM; when it is closed, go to an emergency room for severe symptoms.

What happens at your first follow-up?

Your provider reviews how the first weeks went and decides the next step, in person in Ocala or by telehealth while you're physically in Florida. Bring notes on each dose, any side effects and when they started, how you're eating and drinking, and any new medicine.

Your provider may keep your dose, raise it or give your body more time; the label for FDA-approved semaglutide bases the long-term dose on how well it works and is tolerated. Judge progress over months, not weeks: NIDDK says most weight loss on these medicines takes place within the first 6 months. How we personalize your plan covers the months ahead.

What does the first month cost at Padgett in Ocala?

At the starting dose, personalized compounded semaglutide is $149 a month. The monthly price is your medication. Your provider visit is $100 and is free when you start medication at that visit; the only other charge is a $50 no-show fee. Pricing is by dose, so your price can change when your dose does; see personalized compounded semaglutide pricing by dose.

Booking online is free. A card on file holds your visit, and if you book without one, it isn't confirmed until staff reach you by phone. There's no contract. The no-show fee applies only to a visit you miss, or don't cancel or reschedule at least 24 hours before, and it can be applied to your next visit. Paying without insurance? See personalized compounded semaglutide without insurance.

Questions first? Ask for the free consultation, a free 15-minute phone call with the medical staff; it is not a visit with the provider and nothing is prescribed on it. When you're ready, book a weight-loss visit in person in Ocala or by telehealth anywhere in Florida, or call (352) 369-0104.

Personalized compounded semaglutide and personalized compounded tirzepatide are compounded drugs that have not been approved by the FDA. They have not been reviewed by the FDA for safety, effectiveness, or quality. FDA-approved products containing semaglutide and tirzepatide are available. Individual results vary.

This article is educational and is not medical advice. Talk with a licensed provider about your own health, medications and treatment options.